SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-012707
Filing Date
2019-04-24
Accepted
2019-04-24 16:07:36
Documents
5
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A myok-defa14a_20190430.htm DEFA14A 31457
2 GRAPHIC gqwapl3qnk2n000003.jpg GRAPHIC 35019
3 GRAPHIC gqwapl3qnk2n000004.jpg GRAPHIC 7877
4 GRAPHIC gqwapl3qnk2n000002.jpg GRAPHIC 68336
5 GRAPHIC gqwapl3qnk2n000001.jpg GRAPHIC 36581
  Complete submission text file 0001564590-19-012707.txt   236583
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37609 | Film No.: 19763922
SIC: 2834 Pharmaceutical Preparations